Return to Faculty Profiles

Faculty


Amy Z. Wang

Assistant Professor of Pharmacy Practice, Full-timeClinical Pharmacy Specialist in Cardiology, Mt. Sinai-St. Luke’s Hospital

Pharm.D., University of Kentucky College of PharmacyM.B.A., University of Kentucky, Gatton College of Business & Economics

Description

Dr. Wang is an Assistant Professor of Pharmacy Practice at the Long Island University College of Pharmacy. Her practice site is Mount Sinai- St. Luke’s Hospital, located in New York City, where she rounds with the Cardiology Team. Dr. Wang received both a Doctor of Pharmacy degree and an MBA degree from the University of Kentucky in 2006. She went on to complete a Post-Graduate Year One Pharmacy Practice Residency at the St. John’s Hospital and Medical Center in 2008, and a Post-Graduate Year Two Critical Care Residency at the New York Methodist Hospital in 2009. Her teaching interests include pharmacodynamics, antiarrhythmics, and theophylline. She currently serves on the Assessment Committee and the Scholastic Committee at the LIU College of Pharmacy, and has numerous publications on topics related to cardiology, arrhythmias, antiplatelets, and anticoagulation. Current research interests include novel anticoagulants and students’ perceptions of case presentations. She has been a member of the Editorial Board for the Journal of Developing Drugs since 2012.

Specialties

Cardiology, anticoagulation

Research Interests:

  • Antiplatelets (aspirin, clopidogrel, etc.) in the management of acute coronary syndrome
  • Anticoagulants (warfarin, rivaroxaban, apixaban, dabigatran) in the management of atrial fibrillation
  • Safety of blood thinners in patients with impaired renal function
  • Interruption of novel anticoagulants (dabigatran, rivaroxaban, apixaban) in the perioperative setting
  • Factors for anticoagulation conversions
  • Pharmacy students' perceptions of pharmacy educations based on current job market
  • Pharmacy students' perceptions of presentations while on experiential rotations

Publications

Peer-Reviewed Publications

Nguyen T, Wang A, Kim S. The Roles of Intravenous Iron Therapy in Various Patient Settings – Practical Information for Practitioners.  J Pharm Technol 2010; 26: 285-292.

Nguyen T, Wang A.  , “Hyperphosphatemia: Consequences and Management Strategies.”, J Nurse Pract 2012; 8: 56-60.

Wang A., “Efficacy of Class III Antiarrhythmics and Magnesium Combination Therapy for Atrial Fibrillation. “, Pharm Practice 2012; 10(2): 65-71.

Nguyen T, Wang A., “New anticoagulation medications for atrial fibrillation [editorial].” J Dev Drugs 2013; 2: e123.

Wang A., “Cangrelor: a new kind of antiplatelet therapy [editorial].” J Develop Drugs 2013; 2: e131.

Wang A, Lella LK, Brener S., “Efficacy and safety of prasugrel compared to clopidogrel for patients with acute coronary syndrome undergoing percutaneous coronary intervention.” Am J Ther 2014 Jun 17: [Epub ahead-of-print].

Chen S, Khusial T, Patel D, Singh S, Yakubova T, Wang A, Nguyen T., “Digoxin Use in Modern Medicine.” US Pharm Feb 2015; 40(2): 44-48.

Other Publications

Scientific abstract:

Abraham T, Saad N, Vastey F, Balmir E, Wang A.  Drug Use Evaluation of Protamine and Phytonadione: Are the Doses Appropriate? Pharmacotherapy 2009; 29: 92e.

Newsletter:

New York Methodist Hospital Pharmacy Department Newsletter.  March 2009, volume 5, issue 3.

Abstracts/Poster Presentations

“Medication Use Evaluation of Bivalirudin and Eptifibatide for Percutaneous Coronary Intervention”
Wang A
, Weber K, Moser L, Nikolavsky M, and Dehoorne-Smith M.
December 5, 2007
42nd ASHP Midyear Clinical Meeting and Exhibition
Venetian Resort and Sands Expo Center
Las Vegas, NV

“Drug Use Evaluation of Protamine and Phytonadione: Are the Doses Appropriate?”
Wang A, Saad N, Vastey F, Balmir E, and Abraham T.
December 10, 2008
43rd ASHP Midyear Clinical Meeting and Exhibition
Orange County Convention Center
Orlando, FL

“Drug Use Evaluation of Protamine and Phytonadione: Are the Doses Appropriate?”
Abraham T, Saad N, Vastey F, Balmir E, Wang A.
2009 American College of Clinical Pharmacy/ European Society for Clinical Pharmacy International Congress on Clinical Pharmacy
April 25, 2009
Rosen Centre Hotel
Orlando, FL

“Mortality Risk Factors Associated with Critically Ill Patients: A Retrospective Study.”
Wang A, Abraham T, Saad N, Vastey F, Balmir E.
2009 Eastern States Conference
April 29, 2009
Hershey Lodge
Hershey, PA

“Medication Use Evaluation of Dabigatran”
46th ASHP Midyear Clinical Meeting and Exhibition
December 6, 2011
New Orleans Ernest N. Morial Convention Center
New Orleans, LA

Other Professional Activities

Editorial Board Member, Journal for Developing Drugs

Reviewer, Pharmacy Practice Journal 

Reviewer, American Journal of Health-System Pharmacy

Reviewer, Journal of Pharmacy Practice

Professional Affiliations

Member, American Associations of Colleges of Pharmacy